Patient monitoring devices discussed in the report include, hemodynamic monitor, continuous blood glucose monitor, neuromonitor, cardiac monitor, respiratory monitor and anesthesia monitors, fetal & neonatal monitoring devices, and multi-parameter monitors.
The global patient monitoring devices market is estimated to account for US$ 22,869.5 Mn in terms of value in 2020 and is expected to reach US$ 35,209.0 Mn by the end of 2027.
Browse Research Report: https://www.coherentmarketinsights.com/market-insight/patient-monitoring-devices-market-3991
Global Patient Monitoring Devices Market: Drivers
Launch of new products is expected to propel growth of the global patient monitoring devices market over the forecast period. For instance, in December 2019, Nihon Kohden Corporation launched its Life Scope SVM-7200 Series vital signs monitor, a monitor designed for outpatient facilities and beds, to quickly and easily measure three vital signs – blood oxygen, blood pressure and temperature.
Global Patient Monitoring Devices Market: Opportunities
Development of web-based remote cardiac monitoring solutions is expected to offer lucrative growth opportunities for players in the global patient monitoring devices market. For instance, in November 2019, Bittium Corporation, a Finland-based cardiology and neurology device company, presented Bittium HolterPlus, a web-based remote cardiac monitoring solution, consisting of a Bittium Faros ECG device and Bittium HolterPlus mobile application, at Medica 2019, a leading international trade fair for the medical sector that was held in Germany.
Get PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-pdf/3991
Global Patient Monitoring Devices Market: Restraints
Product recalls are expected to hinder growth of the market. For instance, in February 2020, GE Healthcare Inc. announced to recall 165 patient monitoring devices in the U.S. because of a manufacturing issue that may cause them to display incorrect oxygen values in patients.
Key Takeaways:
The global patient monitoring devices market was valued at US$ 21,505.5 Mn in 2019 and is forecast to reach a value of US$ 35,209.0 Mn by 2027 at a CAGR of 6.4% between 2020 and 2027. Major factor driving the growth of global patient monitoring devices market during the forecast period include increasing prevalence of diseases, and technologically advanced product launches.
Respiratory and Anesthesia Monitors held dominant position in the global patient monitoring devices market in 2019, accounting for 30.8% share in terms of value. Increasing number of patients suffering from several diseases such as cardiovascular diseases, and cancer, are expected to support growth of the segment.
Browse Press Release: https://www.coherentmarketinsights.com/press-release/patient-monitoring-devices-market-3259
Market Trends
Major players in the market are also focused on adopting M&A strategies to expand their product portfolio. For instance, in April 2019, Edwards Lifesciences Corporation acquired CAS Medical Systems, Inc., a medical technology company focused on non-invasive brain and tissue oxygenation monitoring.
Major players in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in April 2019, VivaQuant, a digital health company, received the U.S. FDA clearance for its RX-1 wearable device that can operate as a Holter monitor.
Global Patient Monitoring Devices Market: Competitive Landscape
Major players operating in the global patient monitoring devices market include, 3M Healthcare, Boston Scientific Corporation, Covidien, Draegerwerk AG and Co. KGaA, GE Healthcare, Medtronic Plc, Mindray Medical, Omron, Nihon Kohden Corporation, Biotricity Inc., Bittium Corporation, DexCom, Inc., Caretaker Medical, Shimmer, Edwards Lifesciences Corporation, Saranas, Inc., DiaMonTech GmbH, VivaQuant, and Philips Healthcare.
Global Patient Monitoring Devices Market: Key Developments
November 2019: Saranas, Inc. announced completion of the first U.S. commercial case using the Early Bird Bleed Monitoring System for real-time detection and monitoring of endovascular bleed complications.
January 2019: Eris Lifesciences, a chronic drugs provider, collaborated with India Medtronic Pvt. Ltd, a wholly owned subsidiary of Medtronic plc, to offer its U.S. FDA approved Guardian Connect device, a Smart Continuous Glucose Monitoring System for real-time evaluation of glucose variability in diabetes patients in India.
Got any Query? Feel free to ask us at: https://www.coherentmarketinsights.com/insight/talk-to-analyst/3991
Segmentation
- By Device Type
- Respiratory and Anesthesia Monitors
- Neuro monitoring devices
- Hemodynamic Monitor
- Fetal and neonatal monitors
- Cardiac Monitors
- Multi-Parameter Monitors
- Others (temperature and weight monitors, etc)
- By End-User
- Home Healthcare
- Hospitals
- Others (Outpatient Facilities, research and diagnostic centers)
- By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
